Emerging around 1890, the development of antitoxin therapy represented a significant milestone in the field of immunology. This innovative approach involved the use of immune serum to neutralise the harmful toxins produced by specific disease-causing organisms. By shifting the focus towards the biochemical mechanisms of infection, this method demonstrated how rigorous laboratory science could be harnessed to create targeted medical treatments for patients suffering from severe bacterial illnesses.

The therapy proved particularly transformative in the management of diphtheria, a condition that had previously caused widespread mortality. By isolating and administering the protective components of the immune response, researchers were able to provide a direct defence against the toxins that caused the most acute symptoms of the disease. This breakthrough not only saved countless lives but also provided a foundational understanding of how the body interacts with pathogens at a molecular level.

The success of antitoxin therapy helped to establish the following key principles in medical science:

• The potential for using immune serum to neutralise bacterial toxins.
• The efficacy of laboratory-based research in developing clinical treatments.
• The importance of targeted interventions for specific infectious diseases.
• The transition towards modern immunotherapeutic practices.

As the practice matured, it reinforced the growing belief that scientific inquiry could lead to precise, life-saving interventions. By proving that the immune system could be assisted through external biological preparations, antitoxin therapy paved the way for future advancements in vaccines and serum-based treatments, cementing its place as a cornerstone of modern medical history.